Author:
Engle Janet P.,Kraus Donna M.,Parent Louise S.,Dean-Holland Mary
Reference92 articles.
1. Stewart, C.W., and Fleming, R.A. 1989. Biotechnology products: New opportunities and responsibilities for the pharmacist. Am. J. Hosp. Pharm. 46: S4–S8.
2. Miscellaneous antineoplastics. Facts and comparisons 1991. May:682–683.
3. Petkau, A. 1986. Scientific basis for the clinical use of superoxide dismutase. Cancer Treat. Rev. 13: 17–44.
4. Murohara, Y., Yoshiki, Y., Hattori, R., and Kawai, C. 1991. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. Am. J. Cardiol. 67: 765–767.
5. Hohe, L. 1988. Superoxide dismutase for therapeutic use: Clinical experience, dead ends and hopes. Mol. Cell. Biochem. 84: 123–31.